Key Takeaways Cronos revenues rose 21% year over year in Q2 2025 to $33.5 million.Strong demand in Germany and Israel lifted gross margins to 43%.Net loss widened to $40M, pressured by currency and regulatory costs.One of the leading Canadian cannabis producers, Cronos Group’s (CRON) stock hit $2.50 apiece on Thursday, close to its 52-week high of $2.77.This growth in share price was primarily driven by hopes of federal reforms in the United States and robust international sales growth. Signs of margin impr ...